Sunflower Therapeutics, PBC

Biotechnology company · Hingham, Massachusetts, United States

Sunflower Therapeutics, PBC is a biotechnology company headquartered in Hingham, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $306,347 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2024.

www.sunflowertx.comProfile compiled from public records. Is this your company? Request a correction or update

Sunflower Therapeutics, PBC at a glance

Typebiotechnology company
HeadquartersHingham, Massachusetts, United States
Earliest incorporation on record2022
Employees (self-reported, 2025)13
SEC CIK1950773

What does Sunflower Therapeutics, PBC do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $306,347 in total (2025). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $2 million sold (2024).

Frequently asked questions about Sunflower Therapeutics, PBC

Where is Sunflower Therapeutics, PBC headquartered?

Sunflower Therapeutics, PBC is headquartered in Hingham, Massachusetts, United States.

What does Sunflower Therapeutics, PBC do?

Sunflower Therapeutics, PBC is a biotechnology company.

When was Sunflower Therapeutics, PBC founded?

The earliest incorporation on record for Sunflower Therapeutics, PBC is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences